abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
34476: Neuron Specific Enolase (NSE) Print View
Neuron Specific Enolase EIA  < 10.8  ng/mL 

PRIMARY
1 Serum 1 (0.2) mL   Room Temperature - 7 Day(s)/Refrigerated - 14 Day(s)/Frozen - 30 Day(s)  
ALTERNATE

Elevated levels of serum NSE are reported in patients with small cell carcinomas primarily of lung origin. Patients with neuroblastomas may also have high levels of NSE. Serum NSE can be used to monitor recurrence or progression of tumor in these cancer patients. Daily serial monitoring of serum NSE may also be used in comatose patients to assess neuronal damage. High NSE levels in comatose patients at 24hr and 48hr post cardio-pulmonary resusitation have been associated with poor outcome. Hemolysis can cause false positive results.

Transport Temperature: Room temperature
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
Same day

CPT Code
86316

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Diagnostic code required for third party reimbursement. For Serial Graphic reporting, you must provide the patient's Social Security Number. For NSE detection in tissue, see IHC NSE Block, #IHC48. This test(s) was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute, Valencia, CA. Performance characteristics refer to the analytical performance of the test.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database